Figure S9.

Summary of alteration frequency of GEPSCNEC vs. GEPLCNEC. (A) Oncoprints showing the top most frequent and significant gene alterations between GEPSCNEC and GEPLCNEC; (B) Bar plots of pathway alteration proportions of GEPSCNEC and SCLC; (C) Bar plots of pathway alteration proportions of GEPLCNEC and LCLC. GEPSCNEC, gastroenteropancreatic small-cell neuroendocrine carcinoma; GEPLCNEC, gastroenteropancreatic large-cell neuroendocrine carcinoma; SCLC, small-cell lung cancer; LCLC, large-cell lung cancer. P values were determined using Fisher’s exact test. *, P<0.05; **, P<0.01.